Cancer ColonDICHIMIONCT03722121
Is the Distance of Patients From Rouen University Hospital Influencing the Time Between Colectomy and First Chemotherapy Cure for Colon Cancer?
An observational study of Cancer Colon and Colectomy, run by University Hospital, Rouen at 1 site in France.
Trial summary
This project has for objective to demonstrate that the increase of the distance "Patient home - center of treatment" may be associated with significant, other noticeable, noted events. This distance may also be available in the Rouen University Hospital. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Cancer Colon, Colectomy, Chemotherapy
- How many people
- 140 participants
- Where
- 1 siteFrance
- Study dates
- 23 Mar 2017to 23 Jan 2018
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patient having a cancer colon and hospitalized for colectomy: malignant tumor colon, in situ colon carcinoma or tumor with unpredictable or unknown evolution of the colon
Who may be able to join
- Patients who had colectomy for colon cancer and at least one chemotherapy treatment at CHU Rouen, between 2009 and the first half of 2015.
Who cannot join
- Patients who died in hospital before receiving a chemotherapy treatment
- Patients with a CIM code of metastasis during the stay of the colectomy or the first chemotherapy treatment
- Patients who received a chemotherapy treatment before colectomy
- Patients who have undergone several colectomies.
Trial locations and contacts
1 site in 1 country.
About this study
This project has for objective to demonstrate that the increase of the distance "Patient home - center of treatment" may be associated with significant, other noticeable, noted events. This distance may also be available in the Rouen University Hospital. The study of the association in this distance and the delay in initiating chemotherapy after surgery in patients treated at the CHU correspond to a pilot study prior to the completion of the analysis at the regional scale.
- Conditions
- Cancer Colon, Colectomy, Chemotherapy
- Keywords
- distance
- Medical subject headings
- Colonic Neoplasms
What is being measured
The primary outcome is the main question the study is designed to answer.
distance "home of patients - treatment center"
Analyze the influence of distance "home of patients - treatment center" on the compliance of the time between colectomy and initiation of CTa
Measured: At the inclusion
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Oct 2018
- Study start23 Mar 2017
- Primary completion23 Jan 2018
- Study completion23 Jan 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Cancer ColonStudies of the same condition, open and under way.
- More trials run by University Hospital, RouenThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 140 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Rouen
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03722121
- Sponsor's protocol ID
- 2016/264/HP
- Acronym
- DICHIMIO
- Status last verified
- Apr 2026
- First submitted
- 27 Oct 2017
- Last updated
- 12 May 2026
- Results posted
- No
- Data monitoring committee
- No
Publications
Conformité du délai d'initiation de la chimiothérapie adjuvante pour cancer du côlon : élaboration d'un indicateur qualité à partir du PMSI - T. Vermeulin1, M. Lucas1, H. Lahbib1, L. Froment1, P. Czernichow1, V. Josset1, F. Jusot2, F. Di Fiore3, G. Launoy4 et V. Merle1* - 10.3166/onco-2018-0014
Study at a glance
From the registry record, last updated by the sponsor on 12 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Is the Distance of Patients From Rouen University Hospital Influencing the Time Between Colectomy and First Chemotherapy Cure for Colon Cancer?
- ClinicalTrials.gov ID
- NCT03722121
- Acronym / sponsor ID
- DICHIMIO / 2016/264/HP
- Conditions
- Cancer Colon, Colectomy, Chemotherapy
- Keywords
- distance
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 140 participants (actual)
- Lead sponsor
- University Hospital, RouenUniversity, hospital or other
- Study start
- 23 Mar 2017 (actual)
- Primary completion
- 23 Jan 2018 (actual)
- Study completion
- 23 Jan 2018 (actual)
- First posted
- 26 Oct 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This project has for objective to demonstrate that the increase of the distance "Patient home - center of treatment" may be associated with significant, other noticeable, noted events. This distance may also be available in the Rouen University Hospital. The study of the association in this distance and the delay in initiating chemotherapy after surgery in patients treated at the CHU correspond to a pilot study prior to the completion of the analysis at the regional scale.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patient having a cancer colon and hospitalized for colectomy: malignant tumor colon, in situ colon carcinoma or tumor with unpredictable or unknown evolution of the colon
Key inclusion criteria (1 listed)
- Patients who had colectomy for colon cancer and at least one chemotherapy treatment at CHU Rouen, between 2009 and the first half of 2015.
Key exclusion criteria (4 listed)
- Patients who died in hospital before receiving a chemotherapy treatment
- Patients with a CIM code of metastasis during the stay of the colectomy or the first chemotherapy treatment
- Patients who received a chemotherapy treatment before colectomy
- Patients who have undergone several colectomies.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
distance "home of patients - treatment center"
Time frame: At the inclusion
Analyze the influence of distance "home of patients - treatment center" on the compliance of the time between colectomy and initiation of CTa
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 May 2026.
- Results publicationConformité du délai d'initiation de la chimiothérapie adjuvante pour cancer du côlon : élaboration d'un indicateur qualité à partir du PMSI - T. Vermeulin1, M. Lucas1, H. Lahbib1, L. Froment1, P. Czernichow1, V. Josset1, F. Jusot2, F. Di Fiore3, G. Launoy4 et V. Merle1* - 10.3166/onco-2018-0014
Related trials for Cancer Colon
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
Active, not recruiting
Streamlined Geriatric and Oncological Evaluation Based On IC Technology
Breast Cancer, Comorbidities and Coexisting Conditions
Enrolling by invitationObservational study
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Prostate Cancer, Leukemia
RecruitingPhase 2
Tislelizumab in People With Colorectal Cancer
Colorectal Cancer
Not yet recruitingPhase 2
Alberta Cancer Exercise Dose in Colorectal Cancer
Cancer, Colorectal Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer Colon and Colectomy, run by University Hospital, Rouen at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
distance "home of patients - treatment center" (time frame: At the inclusion). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03722121, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2026.